Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2013

01-09-2013 | Original Article

Normal rates of whole-body fat oxidation and gluconeogenesis after overnight fasting and moderate-intensity exercise in patients with medium-chain acyl-CoA dehydrogenase deficiency

Authors: Hidde H. Huidekoper, Mariëtte T. Ackermans, René Koopman, Luc J. C. van Loon, Hans P. Sauerwein, Frits A. Wijburg

Published in: Journal of Inherited Metabolic Disease | Issue 5/2013

Login to get access

Abstract

Background

Impairments in gluconeogenesis have been implicated in the pathophysiology of fasting hypoglycemia in medium-chain acyl-CoA dehydrogenase deficiency. However, whole body glucose and fat metabolism have never been studied in vivo.

Methods

Stable isotope methodology was applied to compare fat and glucose metabolism between four adult patients with MCADD and four matched controls both at rest and during 1.5 h of moderate-intensity exercise. Additionally, intramyocellular lipid and glycogen content and intramyocellular acylcarnitines were assessed in muscle biopsies collected prior to and immediately after cessation of exercise.

Results

At rest, plasma FFA turnover was significantly higher in patients with MCADD, whereas the plasma FFA concentrations did not differ between patients and controls. Blood glucose kinetics did not differ between groups both at rest and during exercise. Palmitate and FFA turnover, total fat and carbohydrate oxidation rates, the use of muscle glycogen and muscle derived triglycerides during exercise did not differ between patients and controls. Plasma FFA oxidation rates were significantly lower in patients at the latter stages of exercise. Free carnitine levels in muscle were lower in patients, whereas no differences were detected in muscle acetylcarnitine levels.

Conclusions

Whole-body or skeletal muscle glucose and fat metabolism were not impaired in adult patients with MCADD. This implies that MCADD is not rate limiting for energy production under the conditions studied. In addition, patients with MCADD have a higher FFA turnover rate after overnight fasting, which may stimulate ectopic lipid deposition and, as such, make them more susceptible for developing insulin resistance.
Literature
go back to reference Ackermans MT, Pereira Arias AM, Bisschop PH, Endert E, Sauerwein HP, Romijn JA (2001) The quantification of gluconeogenesis in healthy men by 2H2O and [2-13C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with 2H2O are higher than those measured with [2-13C]glycerol. J Clin Endocrinol Metab 86:2220–2226PubMed Ackermans MT, Pereira Arias AM, Bisschop PH, Endert E, Sauerwein HP, Romijn JA (2001) The quantification of gluconeogenesis in healthy men by 2H2O and [2-13C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with 2H2O are higher than those measured with [2-13C]glycerol. J Clin Endocrinol Metab 86:2220–2226PubMed
go back to reference Bergstrom J (1975) Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35:609–616CrossRefPubMed Bergstrom J (1975) Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35:609–616CrossRefPubMed
go back to reference Boden G (2004) Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 52:375–378CrossRefPubMed Boden G (2004) Gluconeogenesis and glycogenolysis in health and diabetes. J Investig Med 52:375–378CrossRefPubMed
go back to reference Derks TG, Reijngoud DJ, Waterham HR et al (2006) The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Pediatr 148:665–670CrossRefPubMed Derks TG, Reijngoud DJ, Waterham HR et al (2006) The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Pediatr 148:665–670CrossRefPubMed
go back to reference Derks TG, van Spronsen FJ, Rake JP, van der Hilst CS, Span MM, Smit GP (2007) Safe and unsafe duration of fasting for children with MCAD deficiency. Eur J Pediatr 166:5–11CrossRefPubMed Derks TG, van Spronsen FJ, Rake JP, van der Hilst CS, Span MM, Smit GP (2007) Safe and unsafe duration of fasting for children with MCAD deficiency. Eur J Pediatr 166:5–11CrossRefPubMed
go back to reference Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628–634PubMed Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628–634PubMed
go back to reference Griffith AD, Cyr DM, Egan SG, Tremblay GC (1989) Inhibition of pyruvate carboxylase by sequestration of coenzyme A with sodium benzoate. Arch Biochem Biophys 269:201–207CrossRefPubMed Griffith AD, Cyr DM, Egan SG, Tremblay GC (1989) Inhibition of pyruvate carboxylase by sequestration of coenzyme A with sodium benzoate. Arch Biochem Biophys 269:201–207CrossRefPubMed
go back to reference Halldin MU, Forslund A, von Dobeln U, Eklund C, Gustafsson J (2007) Increased lipolysis in LCHAD deficiency. J Inherit Metab Dis 30:39–46CrossRefPubMed Halldin MU, Forslund A, von Dobeln U, Eklund C, Gustafsson J (2007) Increased lipolysis in LCHAD deficiency. J Inherit Metab Dis 30:39–46CrossRefPubMed
go back to reference Heales SJ, Thompson GN, Massoud AF, Rahman S, Halliday D, Leonard JV (1994) Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 17:74–80CrossRefPubMed Heales SJ, Thompson GN, Massoud AF, Rahman S, Halliday D, Leonard JV (1994) Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 17:74–80CrossRefPubMed
go back to reference Huidekoper HH, Schneider J, Westphal T, Vaz FM, Duran M, Wijburg FA (2006) Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency. J Inherit Metab Dis 29:631–636CrossRefPubMed Huidekoper HH, Schneider J, Westphal T, Vaz FM, Duran M, Wijburg FA (2006) Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency. J Inherit Metab Dis 29:631–636CrossRefPubMed
go back to reference Jeukendrup AE, Raben A, Gijsen A et al (1999) Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion. J Physiol 515(Pt 2):579–589CrossRefPubMedPubMedCentral Jeukendrup AE, Raben A, Gijsen A et al (1999) Glucose kinetics during prolonged exercise in highly trained human subjects: effect of glucose ingestion. J Physiol 515(Pt 2):579–589CrossRefPubMedPubMedCentral
go back to reference Kean EA, Pogson CI (1979) Inhibition of gluconeogenesis in isolated rat liver cells by methylenecyclopropylpyruvate (ketohypoglycin). Biochem J 182:789–796CrossRefPubMedPubMedCentral Kean EA, Pogson CI (1979) Inhibition of gluconeogenesis in isolated rat liver cells by methylenecyclopropylpyruvate (ketohypoglycin). Biochem J 182:789–796CrossRefPubMedPubMedCentral
go back to reference Koopman R, Schaart G, Hesselink MK (2001) Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116:63–68PubMed Koopman R, Schaart G, Hesselink MK (2001) Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116:63–68PubMed
go back to reference Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G (1985) Variability of aerobic performance in the laboratory and its physiologic correlates. Int J Sports Med 6:197–201CrossRefPubMed Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G (1985) Variability of aerobic performance in the laboratory and its physiologic correlates. Int J Sports Med 6:197–201CrossRefPubMed
go back to reference Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC (1996) Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98:378–385CrossRefPubMedPubMedCentral Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC (1996) Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98:378–385CrossRefPubMedPubMedCentral
go back to reference Orngreen MC, Norgaard MG, Sacchetti M, van Engelen BG, Vissing J (2004) Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency. Ann Neurol 56:279–283CrossRefPubMed Orngreen MC, Norgaard MG, Sacchetti M, van Engelen BG, Vissing J (2004) Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency. Ann Neurol 56:279–283CrossRefPubMed
go back to reference Orngreen MC, Duno M, Ejstrup R et al (2005) Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann Neurol 57:60–66CrossRefPubMed Orngreen MC, Duno M, Ejstrup R et al (2005) Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann Neurol 57:60–66CrossRefPubMed
go back to reference Peronnet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16:23–29PubMed Peronnet F, Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16:23–29PubMed
go back to reference Previs SF, Hazey JW, Diraison F, Beylot M, David F, Brunengraber H (1996) Assay of the deuterium enrichment of water via acetylene. J Mass Spectrom 31:639–642CrossRefPubMed Previs SF, Hazey JW, Diraison F, Beylot M, David F, Brunengraber H (1996) Assay of the deuterium enrichment of water via acetylene. J Mass Spectrom 31:639–642CrossRefPubMed
go back to reference Reinauer H, Gries FA, Hubinger A, Knode O, Severing K, Susanto F (1990) Determination of glucose turnover and glucose oxidation rates in man with stable isotope tracers. J Clin Chem Clin Biochem 28:505–511PubMed Reinauer H, Gries FA, Hubinger A, Knode O, Severing K, Susanto F (1990) Determination of glucose turnover and glucose oxidation rates in man with stable isotope tracers. J Clin Chem Clin Biochem 28:505–511PubMed
go back to reference Roe CR, Ding J (2001) Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL et al (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 2297–2326 Roe CR, Ding J (2001) Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL et al (eds) The metabolic and molecular bases of inherited disease. McGraw Hill, New York, pp 2297–2326
go back to reference Romijn JA, Coyle EF, Sidossis LS et al (1993) Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 265:E380–E391PubMed Romijn JA, Coyle EF, Sidossis LS et al (1993) Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 265:E380–E391PubMed
go back to reference Rosenblatt J, Wolfe RR (1988) Calculation of substrate flux using stable isotopes. Am J Physiol 254:E526–E531PubMed Rosenblatt J, Wolfe RR (1988) Calculation of substrate flux using stable isotopes. Am J Physiol 254:E526–E531PubMed
go back to reference Ruiter AF, Ackermans MT, Endert E (2001) Simultaneous gas chromatographic determination of concentration and isotopic enrichment of fatty acids in human plasma using flame ionization and mass spectrometric detection. J Chromatogr B: Biomed Sci Appl 759:169–174CrossRef Ruiter AF, Ackermans MT, Endert E (2001) Simultaneous gas chromatographic determination of concentration and isotopic enrichment of fatty acids in human plasma using flame ionization and mass spectrometric detection. J Chromatogr B: Biomed Sci Appl 759:169–174CrossRef
go back to reference Saudubray JM, Martin D, de Lonlay P et al (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22:488–502CrossRefPubMed Saudubray JM, Martin D, de Lonlay P et al (1999) Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 22:488–502CrossRefPubMed
go back to reference Schaart G, Hesselink RP, Keizer HA, van Kranenburg G, Drost MR, Hesselink MK (2004) A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections. Histochem Cell Biol 122:161–169CrossRefPubMed Schaart G, Hesselink RP, Keizer HA, van Kranenburg G, Drost MR, Hesselink MK (2004) A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections. Histochem Cell Biol 122:161–169CrossRefPubMed
go back to reference Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR (1995) A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol 269:E649–E656PubMed Sidossis LS, Coggan AR, Gastaldelli A, Wolfe RR (1995) A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol 269:E649–E656PubMed
go back to reference Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420–430CrossRefPubMed Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420–430CrossRefPubMed
go back to reference Tanaka K, Gregersen N, Ribes A et al (1997) A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 variant allele with haplotype analysis at the medium chain Acyl-CoA dehydrogenase gene locus: clinical and evolutionary consideration. Pediatr Res 41:201–209CrossRefPubMed Tanaka K, Gregersen N, Ribes A et al (1997) A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 variant allele with haplotype analysis at the medium chain Acyl-CoA dehydrogenase gene locus: clinical and evolutionary consideration. Pediatr Res 41:201–209CrossRefPubMed
go back to reference van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ (2001) The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536:295–304CrossRefPubMedPubMedCentral van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ (2001) The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536:295–304CrossRefPubMedPubMedCentral
go back to reference van Loon LJ, Koopman R, Schrauwen P, Stegen J, Wagenmakers AJ (2003) The use of the [1,2-13C]acetate recovery factor in metabolic research. Eur J Appl Physiol 89:377–383CrossRefPubMed van Loon LJ, Koopman R, Schrauwen P, Stegen J, Wagenmakers AJ (2003) The use of the [1,2-13C]acetate recovery factor in metabolic research. Eur J Appl Physiol 89:377–383CrossRefPubMed
go back to reference van Vlies N, Tian L, Overmars H et al (2005) Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse. Biochem J 387:185–193CrossRefPubMedPubMedCentral van Vlies N, Tian L, Overmars H et al (2005) Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse. Biochem J 387:185–193CrossRefPubMedPubMedCentral
go back to reference Wanders RJ, Schutgens RB, Zoeters PH (1988) 3-Hydroxy-3-methylglutaryl-CoA lyase in human skin fibroblasts: study of its properties and deficient activity in 3-hydroxy-3-methylglutaric aciduria patients using a simple spectrophotometric method. Clin Chim Acta 171:95–101CrossRefPubMed Wanders RJ, Schutgens RB, Zoeters PH (1988) 3-Hydroxy-3-methylglutaryl-CoA lyase in human skin fibroblasts: study of its properties and deficient activity in 3-hydroxy-3-methylglutaric aciduria patients using a simple spectrophotometric method. Clin Chim Acta 171:95–101CrossRefPubMed
go back to reference Wang SS, Fernhoff PM, Hannon WH, Khoury MJ (1999) Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med 1:332–339CrossRefPubMed Wang SS, Fernhoff PM, Hannon WH, Khoury MJ (1999) Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med 1:332–339CrossRefPubMed
go back to reference Zhang D, Liu ZX, Choi CS et al (2007) Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A 104:17075–17080CrossRefPubMedPubMedCentral Zhang D, Liu ZX, Choi CS et al (2007) Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A 104:17075–17080CrossRefPubMedPubMedCentral
Metadata
Title
Normal rates of whole-body fat oxidation and gluconeogenesis after overnight fasting and moderate-intensity exercise in patients with medium-chain acyl-CoA dehydrogenase deficiency
Authors
Hidde H. Huidekoper
Mariëtte T. Ackermans
René Koopman
Luc J. C. van Loon
Hans P. Sauerwein
Frits A. Wijburg
Publication date
01-09-2013
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2013
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9532-8

Other articles of this Issue 5/2013

Journal of Inherited Metabolic Disease 5/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.